Cohance Lifesciences Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Total Qtr Revenue cr | 550.71 | ||||
| Other Income Qtr Cr | 6.16 | ||||
| Operating Revenues Qtr | 544.55 | ||||
Loading chart... | |||||
Operating Expenses Qtr | 449.20 | ||||
Operating Profit Qtr | 95.35 | ||||
EBITDA Qtr Cr | 96.65 | ||||
Depreciation Qtr | 46.94 | ||||
Net Profit Qtr | 36.72 | ||||
Basic EPS Qtr | 0.96 | ||||